Achaogen, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Net loss
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of (discount) premium on short-term investments
Revaluation of convertible preferred stock warrant
Revaluation of derivative liability
Loss on asset disposition
Stock-based compensation expense
Loss on fixed asset disposals
Impairment relating to restructuring
Change in warrant and derivative liabilities
Loss on debt extinguishment
Loss on settlement of contingently redeemable common stock
Non-cash interest expense relating to notes payable
Non-cash interest expense relating to related-party convertible loan payable
Non-cash restructuring charges
Change in operating assets and liabilities:
Contracts receivable
Trade and contract receivable, net
Prepaids and other assets
Inventory
Other long-term assets
Accounts payable and accrued liabilities
Deferred revenue
Other liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Change in restricted cash
Proceeds from sale of property and equipment
Purchase of short-term investments
Maturities of short-term investments
Proceeds from initial public offering, net of issuance costs
Proceeds from issuance of convertible preferred stock, net of issuance costs
Proceeds from issuance of related-party convertible notes payable
Net cash provided by investing activities

Cash flows from financing activities:
Proceeds from underwritten public offering, net of issuance costs
Proceeds from issuance of contingently redeemable common stock
Proceeds from private placement, net of issuance costs
Proceeds from sales of common stock, net of issuance costs
Proceeds from the issuance of common stock in connection with equity incentive plans
Proceeds from exercise of stock warrants
Proceeds from issuance of related-party convertible loan payable
Proceeds from issuance of notes payable
Proceeds from loan payable, net of issuance costs
Repayment of notes payable
Repurchase of contingently redeemable common stock
Repayment of loan payable
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Net increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of year
Cash, cash equivalents, and restricted cash at end of year
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of year
Cash, cash equivalents, and restricted cash at end of year
Supplemental disclosures of cash flow information
Interest paid
Supplemental disclosures of noncash investing and financing information
Conversion of related-party convertible loan and notes payable to convertible preferred stock
Conversion of convertible preferred stock into common stock
Reclassification of warrant liability to additional paid-in capital
Accrued and deferred public offering issuance cost
Issuance of derivative in connection with issuance of loan payable
Purchases of property and equipment included in accounts payable and accrued liabilities
Purchases of property and equipment included in deferred rent

Transfers of assets held for sale

Comments